isodel PAA – PMC Isochem as CDMO for PolyAmino Acids
See in the following the overview on the usage fields of polyamino acids and the service spectrum of PMC Isochem as CDMO in this area:
Why PolyAmino Acids – PAA
- Functional Excipients
- Biodegradable Polymers
- Drug Delivery & Drug Conjugate
- Alternative to PEG (i.e. polysarcosine)
- Less Immunogenic Choice
- Half-life increase of proteins
A unique Integrated Solution
- Talented & Multidisciplinary R&D team
- Broad network for access cutting-edge technologies
- Integrated NCA supply (Phosgene expert)
- Ring Opening Polymerisation (ROP) technology
- Custom PAA synthesis & tailor-made
- From R&D to commercial supply
PMC Isochem services
- 45 years in large scale Manufacturing under GMP
- RSM, Intermediates, APIs and Excipients
- Analytical Development & QC
- Process development and scale up
- 3 FDA & EU qualified facilities (France)
Preclinical, clinical and commercial batches
- Lean approach to provide faster, better and cost effective solutions
- GMP batches for clinical trials
- Stability studies, process & analytical methods validations, reports…
- Full regulatory support (CMC-DMF Documentation)
Why a PAA based delivery technology?
Growing interest for advanced & new polypeptides backbone
PolyAmino Acids (PAAs) based materials have gained more interest in:
> Drug delivery
> Drug conjugates
PAAs demonstrate remarkable biocompatibility and biodegradability due to the nature of the amino acid monomers building blocks
See the full brochure on “isodel PAA – CDMO for PolyAmino Acids by PMC Isochem“ here
(click the picture to download the brochure)
Source: pmc isochem brochure “isodel PAA – CDMO for PolyAmino Acids by PMC Isochem”
Do you need more information or a sample of isodol PAA excipients?